← Leaderboards
Gregory Scherrer
Columbia University Health Sciences
$14,724,200
Attributed
$20,392,656
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.4M · FY2011–25$20M$15M$10M$5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,030,589 · 14
By mechanism
R01$14,073,961 · 5
U19$8,331,854 · 5
R61$1,299,270 · 1
R00$737,040 · 1
R21$427,625 · 1
K99$160,839 · 1
Top collaborators
- Mark J Schnitzer6 shared
- Hongkui Zeng5 shared
- Aashish Manglik3 shared
- Mark E. Von Zastrow3 shared
- Kevin Yackle3 shared
- Jeffrey Aube1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Edward V Nunes$88,947,598
- Adam Mariusz Bisaga$21,349,874
- Srikumar P Chellappan$11,182,462
- Chioma J Madubata$116,276
- Rajesh Narendran$16,481,808
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsPainElectrophysiology (Science)SliceOpioidInnovationCellsAnalgesicsG-Protein-Coupled ReceptorsSignal TransductionBrainReceptorVentilatory DepressionSide EffectNeural CircuitChronic PainSpinal CordNociceptionMorphineMediatingAcuteMolecularPharmaceutical PreparationsOpioid Receptor
Grant awards (32)
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use$1,397,859
R01 · FY2025 · DA · contact PI
Developing small molecules to engage an analgesic GPCR in pain unpleasantness neural circuits$4,637,933
U19 · FY2024 · NS · contact PI
Assay Development, Screening and Early Optimization$1,576,534
U19 · FY2024 · NS · contact PI
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use$1,401,388
R01 · FY2024 · DA · contact PI
Validation of Therapeutic Target and Underlying Biology$953,058
U19 · FY2024 · NS · contact PI
Development and Validation of Animal Models and/or Outcome Measures$767,756
U19 · FY2024 · NS · contact PI
Targeting GPCRs in amygdalar and cortical neural ensembles to treat pain aversion$705,382
R01 · FY2024 · NS · contact PI
Administrative Core$396,573
U19 · FY2024 · NS · contact PI
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use$1,399,929
R01 · FY2023 · DA · contact PI
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use$1,404,501
R01 · FY2022 · DA · contact PI
Precision pharmacology by local control of opioid receptors in neural circuits$427,965
R61 · FY2022 · DA
Amygdala mechanisms of pain aversion$299,941
R01 · FY2022 · NS · contact PI
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use$1,437,329
R01 · FY2021 · DA · contact PI
Precision pharmacology by local control of opioid receptors in neural circuits$427,965
R61 · FY2021 · DA
Identification of cells and signaling mechanisms underlying opioid analgesia and side effects$349,875
R01 · FY2021 · DA · contact PI
Amygdala mechanisms of pain aversion$303,444
R01 · FY2021 · NS · contact PI
Molecular profiling of medullary descending pain modulation circuits to discover novel analgesic targets$194,375
R21 · FY2021 · DA · contact PI
Targeting GPCRs in amygdalar and cortical neural ensembles to treat pain aversion$2,802,899
R01 · FY2020 · NS · contact PI
Precision pharmacology by local control of opioid receptors in neural circuits$443,340
R61 · FY2020 · DA
Identification of cells and signaling mechanisms underlying opioid analgesia and side effects$349,875
R01 · FY2020 · DA · contact PI
Amygdala mechanisms of pain aversion$325,443
R01 · FY2020 · NS · contact PI
Identification of cells and signaling mechanisms underlying opioid analgesia and side effects$363,978
R01 · FY2019 · DA · contact PI
Molecular profiling of medullary descending pain modulation circuits to discover novel analgesic targets$233,250
R21 · FY2019 · DA · contact PI
Amygdala mechanisms of pain aversion$66,108
R01 · FY2019 · NS · contact PI
Role of Glia in the Formation of Functional Synapses$402,380
R01 · FY2018 · DA · contact PI
Identification of cells and signaling mechanisms underlying opioid analgesia and side effects$363,286
R01 · FY2018 · DA · contact PI
Amygdala mechanisms of pain aversion$337,708
R01 · FY2018 · NS · contact PI
Identification of cells and signaling mechanisms underlying opioid analgesia and side effects$362,636
R01 · FY2017 · DA · contact PI
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a Fo$249,001
R00 · FY2014 · DA · contact PI
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a Fo$239,039
R00 · FY2013 · DA · contact PI
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a Fo$249,000
R00 · FY2012 · DA · contact PI
Analgesic Mechanism of Action of Endogenous Opioid Peptides Enkephalins with a Fo$160,839
K99 · FY2011 · DA · contact PI